First Header Logo Second Header Logo

Connection

Gregory Kucera to Deoxycytidine

This is a "connection" page, showing publications Gregory Kucera has written about Deoxycytidine.
Connection Strength

0.610
  1. Alexander RL, Greene BT, Torti SV, Kucera GL. A novel phospholipid gemcitabine conjugate is able to bypass three drug-resistance mechanisms. Cancer Chemother Pharmacol. 2005 Jul; 56(1):15-21.
    View in: PubMed
    Score: 0.245
  2. Alexander RL, Morris-Natschke SL, Ishaq KS, Fleming RA, Kucera GL. Synthesis and cytotoxic activity of two novel 1-dodecylthio-2-decyloxypropyl-3-phosphatidic acid conjugates with gemcitabine and cytosine arabinoside. J Med Chem. 2003 Sep 11; 46(19):4205-8.
    View in: PubMed
    Score: 0.221
  3. Alexander PM, Caudell DL, Kucera GL, Pladna KM, Pardee TS. The novel phospholipid mimetic KPC34 is highly active against preclinical models of Philadelphia chromosome positive acute lymphoblastic leukemia. PLoS One. 2017; 12(6):e0179798.
    View in: PubMed
    Score: 0.143
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.